Literature DB >> 6458706

Effect of alpha-difluoromethylornithine on cardiac polyamine content and hypertrophy.

A E Pegg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458706     DOI: 10.1016/0022-2828(81)90287-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  5 in total

1.  Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy.

Authors:  Emanuele Giordano; Rebecca A Hillary; Thomas C Vary; Anthony E Pegg; Andrew D Sumner; Claudio M Caldarera; Xue-Qian Zhang; Jianliang Song; JuFang Wang; Joseph Y Cheung; Lisa M Shantz
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

2.  Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy.

Authors:  C A Mackintosh; D J Feith; L M Shantz; A E Pegg
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

3.  Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy.

Authors:  L M Shantz; D J Feith; A E Pegg
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

Review 4.  Biochemical regulators in cardiac hypertrophy.

Authors:  F Kölbel; V Schreiber
Journal:  Basic Res Cardiol       Date:  1983 Jul-Aug       Impact factor: 17.165

5.  Changes in skeletal muscle gene expression following clenbuterol administration.

Authors:  Diane M Spurlock; Tara G McDaneld; Lauren M McIntyre
Journal:  BMC Genomics       Date:  2006-12-20       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.